Sign Up Today and Learn More About Route 92 Medical Stock
Invest in or calculate the value of your shares in Route 92 Medical or other pre-IPO companies through EquityZen's platform.
Route 92 Medical Stock (RNTM)
Route 92 Medical is a medical device company developing a catheter to treat stroke.
About Route 92 Medical Stock
Founded
2015
Headquarters
San Mateo, CA, US
Industries
Messaging and Telecommunications, Sports, Content and Publishing
Route 92 Medical is a developer of a stealthy catheter for stroke treatment. The company was founded in 2015 and based in San Mateo, California.
Route 92 Medical Press Mentions
Stay in the know about the latest news on Route 92 Medical
Aspiration catheter systems and methods of use
patents • Apr 02, 2025
Robotic drive system for facilitating treatments of the neurovasculature and …
patents • Apr 02, 2025
Route 92 Medical Receives Australian Therapeutic Goods Administration Approval for its Portfolio of Neurovascular Interventional Products for Treating Patients with Acute Ischemic Stroke
globenewswire • Mar 27, 2025
First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat Idiopathic Intracranial Hypertension
biospace • Mar 20, 2025
First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat Idiopathic Intracranial Hypertension
globenewswire • Mar 19, 2025
Route 92 Medical Management
Leadership team at Route 92 Medical
Sr. VP Clinical, Regulatory and Quality
Kirsten Valley
Board Member
Ariella Golomb
Join now and verify your accreditation status to gain access to:
- Route 92 Medical Current Valuation
- Route 92 Medical Stock Price
- Route 92 Medical Management
- Available deals in Route 92 Medical and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Route 92 Medical Cap Table and Funding History by Share Class and Liquidity Preferences
- Route 92 Medical Revenue and Financials
- Route 92 Medical Highlights
- Route 92 Medical Business Model
- Route 92 Medical Risk Factors
- Route 92 Medical Research Report from SACRA Research
Trading Route 92 Medical Stock
How to invest in Route 92 Medical stock?
Accredited investors can buy pre-IPO stock in companies like Route 92 Medical through EquityZen funds. These investments are made available by existing Route 92 Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Route 92 Medical stock?
Shareholders can sell their Route 92 Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
